Top

Annals of Hematology

Published in:

01-04-2012 | Letter to the Editor

Effects of tamibarotene for the treatment of adult T cell leukemia

Authors: Yasuhiro Maeda, Masaya Kawauchi, Jun-ichi Miyatake, Chikara Hirase, Terufumi Yamaguchi, Itaru Matsumura

Published in: Annals of Hematology | Issue 4/2012

Excerpt

Dear Editor, …

Maeda Y, Yamaguchi T, Hijikata Y, Tanaka M, Hirase C, Takai S, Morita Y, Sano T, Miyatake JI, Tatsumi Y, Kanamaru A (2008) Clinical efficacy of all-trans retinoic acid for treating adult T-cell leukemia. J Cancer Res Clin Oncol 134:673–677PubMedCrossRef

Yamada Y, Tomonaga M, Fukuda H, Nanada S, Utsunomia A, Tara M et al (2001) A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 113:375–382PubMedCrossRef

Maeda Y, Sasakawa A, Hirase C, Yamaguchi T, Morita Y, Miyatake J, Urase F, Nomura S, Matsumura I (2011) Senescence induction therapy for the treatment of adult T-cell leukemia. Leuk Lymphoma 52:150–152PubMedCrossRef

Sakisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, Chodosh LA (2007) Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Nat Cell Biol 9:493–505CrossRef

Dankort D, Filenova E, Collado M, Serrano M, Jones K, McMohon M (2007) A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. Gene Dev 21:379–384PubMedCrossRef

Lee AC, Fenster BE, Ito H, Takaeda K, Bae NS, Hirai T et al (1999) Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem 274:7936–7940PubMedCrossRef

Title: Effects of tamibarotene for the treatment of adult T cell leukemia
Authors: Yasuhiro Maeda
Masaya Kawauchi
Jun-ichi Miyatake
Chikara Hirase
Terufumi Yamaguchi
Itaru Matsumura
Publication date: 01-04-2012
Publisher: Springer-Verlag
Published in: Annals of Hematology / Issue 4/2012
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-011-1290-4

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Effects of tamibarotene for the treatment of adult T cell leukemia

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2012

Athrombogenic coating of long-term venous catheter for cancer patients: a prospective, randomised, double-blind trial

Gene mutations in the Ras pathway and the prognostic implication in Korean patients with juvenile myelomonocytic leukemia

Cytomegalovirus infection is associated with venous thromboembolism of immunocompetent adults—a case–control study

Phase II trial of rituximab plus CVP combination chemotherapy for advanced stage marginal zone lymphoma as a first-line therapy: Consortium for Improving Survival of Lymphoma (CISL) study

Diagnostic and therapeutic challenges of severe Rh e-specific IgA-mediated autoimmune hemolytic anemia

The role of human leukocyte antigens as predisposing and/or protective factors in patients with idiopathic thrombotic thrombocytopenic purpura

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page